Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi

Wed, 06th May 2026 09:28

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

----------

FTSE 100

----------

Exane BNP raises Spirax to 'outperform' (neutral) - price target 8,350 (7,500) pence

----------

Keefe Bruyette & Woods raises Standard Chartered to 'market perform'

----------

JPMorgan raises Standard Chartered target to 2,220 (2,200) pence - 'overweight'

----------

Shore Capital raises HSBC to 'hold' (sell)

----------

Goldman Sachs raises HSBC price target to 1,700 (1,650) pence - 'buy'

----------

Jefferies cuts NatWest price target to 730 (750) pence - 'buy'

----------

Jefferies raises Barclays price target to 590 (570) pence - 'buy'

----------

Barclays raises Standard Life price target to 690 (660) pence - 'underweight'

----------

Deutsche Bank Research cuts Whitbread price target to 2,530 (2,815) pence - 'hold'

----------

Citigroup cuts GSK price target to 2,100 (2,250) pence - 'neutral'

----------

Bernstein cuts Informa price target to 1,033 (1,060) pence - 'outperform'

----------

Goldman Sachs raises United Utilities price target to 1,523 (1,346) pence - 'neutral'

----------

Goldman Sachs raises Pearson price target to 1,350 (1,300) pence - 'buy'

----------

Goldman Sachs cuts Mondi price target to 800 (910) pence - 'neutral'

----------

FTSE 250

----------

Deutsche Bank cuts Telecom Plus to 'hold' (buy) - price target 1,300 (2,000) pence

----------

Kepler Cheuvreux starts Primary Health Properties with 'buy' - price target 120 pence

----------

Goldman Sachs cuts Dr Martens price target to 71 (76) pence - 'neutral'

----------

Jefferies cuts Paragon Banking price target to 1,000 (1,060) pence - 'buy'

----------

Jefferies cuts OSB price target to 700 (780) pence - 'buy'

----------

SMALL CAP

----------

UBS cuts Fermi to 'neutral' (buy) - price target 6 (8) USD

----------

Berenberg raises Synthomer price target to 100 (60) pence - 'hold'

----------

Berenberg cuts CLS price target to 58 (80) pence - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Broker Recommendations Market News Spirax-Sarco Standard Chartered HSBC Holdings Barclays Natwest Standard Life Whitbread Glaxosmithkline Informa United Utilities Pearson Mondi Telecom Plus Primary Health Dr. Martens Paragon Group OneSavings Bank Fermi Inc CLS Holdings Synthomer

Shares in this article

Related News

Canada's Manulife sets final guidance for Singapore dollar Tier-2 bond at 2.88%; orders top $1 billion
43 mins ago

Canada's Manulife sets final guidance for Singapore dollar Tier-2 bond at 2.88%; orders top $1 billion

SINGAPORE, ‌May 26 (Reuters) - Canadian insurer Manulife Financial Corp has ⁠set final price guidance at 2.88% for ⁠a 10-year Singapore ​dollar-denomi...

Harworth adds Barclays to GBP275 million credit facility syndicate
1 hour ago

Harworth adds Barclays to GBP275 million credit facility syndicate

(Alliance News) - Harworth Group PLC said Barclays PLC has joined the syndicate of existing relationships banks on its GBP275 million revolving credit...

Corporate News Harworth Gp + 3 more shares
LONDON BROKER RATINGS: Barclays ups British Land; BofA cuts Vodafone
2 hours ago

LONDON BROKER RATINGS: Barclays ups British Land; BofA cuts Vodafone

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and Friday: